A new study has revealed how bacteria exploit human proteins during lethal infections.
The research by scientists at the University of York has found how Staphylococcus aureus, which can cause life-threatening human infections, attach to two proteins fibronectin and fibrinogen found in human blood.
The scientists have solved the three dimensional structure of the bacterial protein FnBPA in complex with a small part of the human protein fibrinogen and the findings showed that the fibrinogen binding site on FnBPA is close to, but not overlapping with, the binding site for fibronectin.
Professor Jennifer Potts said that bacteria have evolved various mechanisms to exploit human proteins to cause infection and understanding it might not only lead to the development of new therapeutics but can also provide important information regarding the normal role of these human proteins in the body.
The study was published in the Journal of Biological Chemistry.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
